Frontiers in immunology · 2026
TP53 loss attenuates C1q-associated macrophage remodeling in early adenomatous polyps in a porcine FAP model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chan Qixia, Liang Wei, Flisikowska Tatiana, Ebner Friederike, Flisikowski Krzysztof
Аннотация
BACKGROUND: Familial adenomatous polyposis (FAP) is a hereditary condition that almost invariably leads to colorectal cancer. While TP53 inactivation is well established as a late event in the adenoma-to-carcinoma sequence, its functional role during the early stage of colorectal polyp development remains unclear.
METHODS: Three lines of FAP pigs were generated: APC1311/+ , APC1311/+ /TP53+/- , and APC1311/+ /TP53-/- . Colonic polyp development was evaluated by colonoscopy at 3 and 9 months of age. Mucosal goblet cell and mucin content were assessed using periodic acid-Schiff/Alcian blue (PAS-AB) staining. Immunohistochemistry for Ki67 and IBA1 was performed to assess epithelial proliferation and macrophage/monocyte-like cell infiltration, respectively. Quantitative PCR was used to measure mRNA expression of macrophage/monocyte - and complement-related genes, including CCL2, FCGR3A, ITGAM, and members of the C1q family.
RESULTS: Macroscopic adenomatous polyp burden and growth dynamics were comparable across genotypes. However, APC1311/+ /TP53-/- pigs exhibited significantly reduced epithelial proliferation within polyp crypts, as indicated by decreased Ki67+ expression. Furthermore, immunohistochemistry revealed a significant reduction of stromal IBA1+ macrophage/monocyte-like cells in polyps from APC1311/+ /TP53-/- animals. Consistently, expression levels of CCL2, ITGAM, FCGR3A, and complement components C1QB and C1QC were significantly downregulated.
CONCLUSIONS: Loss of TP53 did not accelerate early-stage adenomatous polyp progression in the FAP pig model. However, TP53 deficiency was associated with significant alterations in the polyp microenvironment, particularly characterized by reduced C1q-associated macrophage remodeling and diminished expression of macrophage/monocyte- and complement-related genes. These findings suggest a role for TP53 in modulating the inflammatory tumor microenvironment during colorectal tumorigenesis.
METHODS: Three lines of FAP pigs were generated: APC1311/+ , APC1311/+ /TP53+/- , and APC1311/+ /TP53-/- . Colonic polyp development was evaluated by colonoscopy at 3 and 9 months of age. Mucosal goblet cell and mucin content were assessed using periodic acid-Schiff/Alcian blue (PAS-AB) staining. Immunohistochemistry for Ki67 and IBA1 was performed to assess epithelial proliferation and macrophage/monocyte-like cell infiltration, respectively. Quantitative PCR was used to measure mRNA expression of macrophage/monocyte - and complement-related genes, including CCL2, FCGR3A, ITGAM, and members of the C1q family.
RESULTS: Macroscopic adenomatous polyp burden and growth dynamics were comparable across genotypes. However, APC1311/+ /TP53-/- pigs exhibited significantly reduced epithelial proliferation within polyp crypts, as indicated by decreased Ki67+ expression. Furthermore, immunohistochemistry revealed a significant reduction of stromal IBA1+ macrophage/monocyte-like cells in polyps from APC1311/+ /TP53-/- animals. Consistently, expression levels of CCL2, ITGAM, FCGR3A, and complement components C1QB and C1QC were significantly downregulated.
CONCLUSIONS: Loss of TP53 did not accelerate early-stage adenomatous polyp progression in the FAP pig model. However, TP53 deficiency was associated with significant alterations in the polyp microenvironment, particularly characterized by reduced C1q-associated macrophage remodeling and diminished expression of macrophage/monocyte- and complement-related genes. These findings suggest a role for TP53 in modulating the inflammatory tumor microenvironment during colorectal tumorigenesis.